SEER site groups based on International Classification of Childhood Cancer, Third Edition (ICCC–3) based on ICD–O–31
Site Group | Histologic Type | Primary Site |
---|---|---|
I Leukemias, myeloproliferative diseases, and myelodysplastic diseases | ||
(a) Lymphoid leukemias | 9820, 9823, 9826, 9827, 9831–9837, 9940, 9948 | C000–C809 |
(b) Acute myeloid leukemias | 9840, 9861, 9866, 9867, 9870–9874, 9891, 9895–9897, 9910, 9920, 9931 | C000–C809 |
(c) Chronic myeloproliferative diseases | 9863, 9875, 9876, 9950, 9960–9964 | C000–C809 |
(d) Myelodysplastic syndrome and other myeloproliferative diseases | 9945, 9946, 9975, 9980, 9982–9987, 9989 | C000–C809 |
(e) Unspecified and other specified leukemias | 9800, 9801, 9805, 9860, 9930 | C000–C809 |
II Lymphomas and reticuloendothelial neoplasms | ||
(a) Hodgkin lymphomas | 9650–9655, 9659, 9661–9665, 9667 | C000–C809 |
(b) Non-Hodgkin lymphomas (except Burkitt lymphoma) | 9591, 9670, 9671, 9673, 9675, 9678–9680, 9684, 9689–9691, 9695, 9698–9702, 9705, 9708, 9709, 9714, 9716–9719, 9727–9729, 9731–9734, 9760–9762, 9764–9769, 9970 | C000–C809 |
(c) Burkitt lymphoma | 9687 | C000–C809 |
(d) Miscellaneous lymphoreticular neoplasms | 9740–9742, 9750, 9754–9758 | C000–C809 |
(e) Unspecified lymphomas | 9590, 9596 | C000–C809 |
III CNS and miscellaneous intracranial and intraspinal neoplasms | ||
(a) Ependymomas and choroid plexus tumor | 9383, 9390–9394 | C000–C809 |
(b) Astrocytomas | 9380 | C723 |
9384, 9400–9411, 9420, 9421–9424, 9440–9442 | C000–C809 | |
(c) Intracranial and intraspinal embryonal tumors | 9470–9474, 9480, 9508 | C000–C809 |
9501–9504 | C700–C729 | |
(d) Other gliomas | 9380 | C700–C722, C724–C729, C751, C753 |
9381, 9382, 9430, 9444, 9450, 9451, 9460 | C000–C809 | |
(e) Other specified intracranial and intraspinal neoplasms | 8270–8281, 8300, 9350–9352, 9360–9362, 9412, 9413, 9492, 9493, 9505–9507, 9530–9539, 9582 | C000–C809 |
(f) Unspecified intracranial and intraspinal neoplasms | 8000–8005 | C700–C729, C751–C753 |
IV Neuroblastoma and other peripheral nervous cell tumors | ||
(a) Neuroblastoma and ganglioneuroblastoma | 9490, 9500 | C000–C809 |
(b) Other peripheral nervous cell tumors | 8680–8683, 8690–8693, 8700, 9520–9523 | C000–C809 |
9501–9504 | C000–C699, C739–C768, C809 | |
V Retinoblastoma | 9510–9514 | C000–C809 |
VI Renal tumors | ||
(a) Nephroblastoma and other nonepithelial renal tumors | 8959, 8960, 8964–8967 | C000–C809 |
8963, 9364 | C649 | |
(b) Renal carcinomas | 8010–8041, 8050–8075, 8082, 8120–8122, 8130–8141, 8143, 8155, 8190–8201, 8210, 8211, 8221–8231, 8240–8241, 8244–8246, 8260–8263, 8290, 8310, 8320, 8323, 8401, 8430, 8440, 8480–8490, 8504, 8510, 8550, 8560–8576 | C649 |
8311–8312, 8316–8319, 8361 | C000–C809 | |
(c) Unspecified malignant renal tumors | 8000–8005 | C649 |
VII Hepatic tumors | ||
(a) Hepatoblastoma | 8970 | C000–C809 |
(b) Hepatic carcinomas | 8010–8041, 8050–8075, 8082, 8120–8122, 8140, 8141, 8143, 8155, 8190–8201, 8210–8211, 8230, 8231, 8240–8241, 8244–8246, 8260–8264, 8310, 8320, 8323, 8401, 8430, 8440, 8480–8490, 8504, 8510, 8550, 8560–8576 | C220, C221 |
8160–8180 | C000–C809 | |
(c) Unspecified malignant hepatic tumors | 8000–8005 | C220–C221 |
VIII Malignant bone tumors | ||
(a) Osteosarcomas | 9180–9187, 9191–9195, 9200 | C400–C419, C760–C768, C809 |
(b) Chondrosarcomas | 9210, 9220, 9240 | C400–C419, C760–C768, C809 |
9221, 9230, 9241–9243 | C000–C809 | |
(c) Ewing tumor and related sarcomas of bone | 9260 | C400–C419, C760–C768, C809 |
9363–9365 | C400–C419 | |
(d) Other specified malignant bone tumors | 8810–8811, 8823, 8830 | C400–C419 |
8812, 9250, 9261, 9262, 9270–9275, 9280–9282, 9290, 9300–9302, 9310–9312, 9320–9322, 9330, 9340–9342, 9370–9372 | C000–C809 | |
(e) Unspecified malignant bone tumors | 8000–8005, 8800–8801, 8803–8805 | C400–C419 |
IX Soft tissue and other extraosseous sarcomas | ||
(a) Rhabdomyosarcomas | 8900–8905, 8910, 8912, 8920, 8991 | C000–C809 |
(b) Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms | 8810, 8811, 8813–8815, 8821, 8823, 8834–8835 | C000–C399, C440–C768, C809 |
8820, 8822, 8824–8827, 9150, 9160, 9491, 9540–9571, 9580 | C000–C809 | |
(c) Kaposi sarcoma | 9140 | C000–C809 |
(d) Other specified soft tissue sarcomas | 8587, 8710–8713, 8806, 8831–8833, 8836, 8840–8842, 8850–8858, 8860–8862, 8870, 8880, 8881, 8890–8898, 8921, 8982, 8990, 9040–9044, 9120–9125, 9130–9133, 9135, 9136, 9141–9142, 9161, 9170–9175, 9231, 9251–9252, 9373, 9581 | C000–C809 |
8830 | C000–C399, C440–C768, C809 | |
8963 | C000–C639, C659–C699, C739–C768, C809 | |
9180, 9210, 9220, 9240 | C490–C499 | |
9260 | C000–C399, C470–C759 | |
9364 | C000–C399, C470–C639, C659–C699, C739–C768, C809 | |
9365 | C000–C399, C470–C639, C659–C768, C809 | |
(e) Unspecified soft tissue sarcomas | 8800–8805 | C000–C399, C440–C768, C809 |
X Germ cell tumors, trophoblastic tumors, and neoplasms of gonads | ||
(a) Intracranial and intraspinal germ cell tumors | 9060–9065, 9070–9072, 9080–9085, 9100, 9101 | C700–C729, C751–C753 |
(b) Malignant extracranial and extragonadal germ cell tumors | 9060–9065, 9070–9072, 9080–9085, 9100–9105 | C000–C559, C570–C619, C630–C699, C739–C750, C754–C768, C809 |
(c) Malignant gonadal germ cell tumors | 9060–9065, 9070–9073, 9080–9085, 9090, 9091, 9100, 9101 | C569, C620–C629 |
(d) Gonadal carcinomas | 8010–8041, 8050–8075, 8082, 8120–8122, 8130–8141, 8143, 8190–8201, 8210–8211, 8221–8241, 8244–8246, 8260–8263, 8290, 8310, 8313, 8320, 8323, 8380–8384, 8430, 8440, 8480–8490, 8504, 8510, 8550, 8560–8573, 9000, 9014–9015 | C569, C620–C629 |
8441–8444, 8450, 8451, 8460–8473 | C000–C809 | |
(e) Other and unspecified malignant gonadal tumors | 8590–8671 | C000–C809 |
8000–8005 | C569, C620–C629 | |
XI Other malignant epithelial neoplasms and malignant melanomas | ||
(a) Adrenocortical carcinomas | 8370–8375 | C000–C809 |
(b) Thyroid carcinomas | 8010–8041, 8050–8075, 8082, 8120–8122, 8130–8141, 8190, 8200, 8201, 8211, 8230, 8231, 8244–8246, 8260–8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480, 8481, 8510, 8560–8573 | C739 |
8330–8337, 8340–8347, 8350 | C000–C809 | |
(c) Nasopharyngeal carcinomas | 8010–8041, 8050–8075, 8082, 8083, 8120–8122, 8130–8141, 8190, 8200–8201, 8211, 8230, 8231, 8244–8246, 8260–8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480, 8481, 8500–8576 | C110–C119 |
(d) Malignant melanomas | 8720–8780, 8790 | C000–C809 |
(e) Skin carcinomas | 8010–8041, 8050–8075, 8078, 8082, 8090–8110, 8140, 8143, 8147, 8190, 8200, 8240, 8246, 8247, 8260, 8310, 8320, 8323, 8390–8420, 8430, 8480, 8542, 8560, 8570–8573, 8940–8941 | C440–C449 |
(f) Other and unspecified carcinomas | 8010–8084, 8120–8157, 8190–8264, 8290, 8310, 8313–8315, 8320–8325, 8360, 8380–8384, 8430–8440, 8452–8454, 8480–8586, 8588–8589, 8940, 8941, 8983, 9000, 9010–9016, 9020, 9030 | C000–C109, C129–C218, C239–C399, C480–C488, C500–C559, C570–C619, C630–C639, C659–C729, C750–C768, C809 |
XII Other and unspecified malignant neoplasms | ||
(a) Other specified malignant tumors | 8930–8936, 8950, 8951, 8971–8981, 9050–9055, 9110 | C000–C809 |
9363 | C000–C399, C470–C759 | |
(b) Other unspecified malignant tumors | 8000–8005 | C000–C218, C239–C399, C420–C559, C570–C619, C630–C639, C659–C699, C739–C750, C754–C809 |
Not Classified by ICCC or in situ |
CNS = central nervous system
ICCC = International Classification of Childhood Cancer
ICD-O-3 = International Classification of Diseases for Oncology, Third Edition
1 Steliarova–Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, Third Edition. Cancer 2005;103:1457–1467.